{
	"kja6ixgoText": "Ka<span class=\"_ _2\"></span>ton<span class=\"_ _c\"></span>a C et al. 2<span class=\"_ _c\"></span>0<span class=\"_ _c\"></span>1<span class=\"_ _3\"></span>2<span class=\"_ _3\"></span><span class=\"fs1 v1\">1</span>",
	"kja6ixgpText": "<div style=\"line-height: 1.1;\">A randomised, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose<br style=\"\"><span class=\"ls4 wsb\">study comparing the efficacy and safety of Brintellix® in elderly patients with MDD.</span><div style=\"margin-top:5px;\"><span class=\"ls4 wsb\" style=\"\">Study objective: <span class=\"ff3\">Investigate the efficacy, safety and tolerability of Brintellix® at 5 mg/day</span></span></div><div class=\"ff3\">compared with placebo over eight weeks in elderly patients with MDD.</div></div>",
	"kja6ixgqText": "Key inclusion criteria ",
	"kja6ixgrText": "P<span class=\"_ _c\"></span>atients with primary<span class=\"_ _0\"></span> <br>diagnosis of MDD<span class=\"_ _0\"></span> <br>according to DSM-IV ",
	"kja6ixgsText": "Current major depressive <br>episode (MDE) of ≥4 weeks’ <br>duration and ≥1 previous <br>MDE before the age of 60<span class=\"_ _0\"></span> ",
	"kja6ixgtText": "Age ≥65 years MADRS of ≥26<span class=\"_ _0\"></span> <br>at screening and baseline ",
	"kja6ixguText": "P<span class=\"_ _c\"></span>atients with a Mini-Mental<span class=\"_ _0\"></span> <br>State Examination (MMSE) <br>score of &lt;24 were <br><span class=\"ws9\">excluded</span>",
	"kja6ixgvText": "<div style=\"text-align: center;\">One-week</div><div style=\"text-align: center;\">double-blind<br></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">taper period</span><br></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">and four-week</span><span style=\"text-align: start;\"><br></span></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">safety</span><span style=\"text-align: start;\"><br></span></div><div style=\"text-align: center;\"><span style=\"text-align: start;\">follow-up</span><span style=\"text-align: start;\"><br></span></div>",
	"kja6ixh1Text": "Back",
	"kja6ixh2Text": "Dulox<span class=\"_ _2\"></span>etine 60 mg/day (n=151)",
	"kja6ixh3Text": "Brintellix® 5 mg/day (n=156)",
	"kja6ixh4Text": "Placebo once daily (n=145)",
	"kja6ixh5Text": "Eight-week double-blind treatment period",
	"kja6ixh6Text": "Randomisation <br><span class=\"ls2a ws85\">1:<span class=\"_ _0\"></span>1:1<span class=\"_ _1\"></span> <br><span class=\"ls3c ws86\">(A<span class=\"_ _0\"></span>P<span class=\"_ _0\"></span>T<span class=\"_ _0\"></span>S<span class=\"_ _0\"></span> n<span class=\"_ _0\"></span>=<span class=\"_ _0\"></span>4<span class=\"_ _0\"></span>52)</span></span>",
	"kja6ixh7Text": "Primary ef<span class=\"_ _0\"></span>ficac<span class=\"_ _0\"></span>y analysis: <span class=\"ff3 ls36 wsb\">chan<span class=\"_ _2\"></span>ge from b<span class=\"_ _2\"></span>asel<span class=\"_ _2\"></span>ine i<span class=\"_ _2\"></span>n the HAM-D<span class=\"fs1c ls3e ws82 v3\">24</span><span class=\"ls5\"> <br></span>total sc<span class=\"_ _2\"></span>ore at w<span class=\"_ _2\"></span>eek 8 [<span class=\"_ _c\"></span>F<span class=\"_ _2\"></span>AS, last obse<span class=\"_ _2\"></span>r<span class=\"_ _0\"></span>vati<span class=\"_ _2\"></span>on carried f<span class=\"_ _2\"></span>orward <br>(<span class=\"_ _2\"></span>L<span class=\"_ _2\"></span>OCF)<span class=\"_ _c\"></span>] and, if a<span class=\"_ _2\"></span>ppl<span class=\"_ _2\"></span>icable<span class=\"_ _c\"></span>, at weeks 6, 4<span class=\"_ _c\"></span>, 2 and 1<span class=\"_ _c\"></span>. </span>",
	"kja6ixh8Text": "Secondary ef<span class=\"_ _0\"></span>ficacy analysis: <span class=\"ff3\">CGI-<span class=\"_ _2\"></span>S and C<span class=\"_ _2\"></span>GI-I wer<span class=\"_ _2\"></span>e also <br>an<span class=\"_ _2\"></span>alysed<span class=\"_ _c\"></span>. Respons<span class=\"_ _2\"></span>e (<span class=\"_ _c\"></span>≥50% d<span class=\"_ _2\"></span>ecre<span class=\"_ _2\"></span>ase fro<span class=\"_ _2\"></span>m basel<span class=\"_ _2\"></span>ine<span class=\"_ _3\"></span>) and remi<span class=\"_ _2\"></span>ssion <br><span class=\"ls3f ws83\">(<span class=\"_ _c\"></span>HAM<span class=\"_ _0\"></span>-D<span class=\"_ _2\"></span><span class=\"fs1c ls40 ws84 v3\">17<span class=\"_ _0\"></span><span class=\"fs18 ls36 wsb v8\"> ≤<span class=\"_ _2\"></span>7<span class=\"_ _3\"></span>, CG<span class=\"_ _2\"></span>I-S<span class=\"_ _2\"></span>≤2<span class=\"_ _c\"></span>) were a<span class=\"_ _2\"></span>nal<span class=\"_ _2\"></span>ysed per vi<span class=\"_ _2\"></span>sit.</span></span></span></span>",
	"kja6ixh9Text": "Predefined exploratory analyses: <span class=\"ff3 ls36 wsb\">The DS<span class=\"_ _2\"></span>ST (<span class=\"_ _c\"></span>number o<span class=\"_ _2\"></span>f <br>correct symbols<span class=\"_ _3\"></span>) and R<span class=\"_ _0\"></span>A<span class=\"_ _c\"></span>VL<span class=\"_ _c\"></span>T (<span class=\"_ _2\"></span>acqu<span class=\"_ _2\"></span>isiti<span class=\"_ _2\"></span>on and d<span class=\"_ _2\"></span>ela<span class=\"_ _2\"></span>yed r<span class=\"_ _2\"></span>ecall<span class=\"_ _c\"></span>) <br>were an<span class=\"_ _2\"></span>alysed a<span class=\"_ _2\"></span>s assessmen<span class=\"_ _2\"></span>ts of cogn<span class=\"_ _2\"></span>itive fun<span class=\"_ _2\"></span>c<span class=\"_ _0\"></span>tion<span class=\"_ _2\"></span>.</span>",
	"kja6ixhaText": "Patients <br><span class=\"ws70\">seen weekly<span class=\"_ _0\"></span> <br><span class=\"ls1a wsb\">for firs<span class=\"_ _0\"></span>t two <br><span class=\"ls2e ws89\">week<span class=\"_ _0\"></span>s, and <br></span></span>then<span class=\"_ _0\"></span> every <br><span class=\"ls42 ws8a\">t<span class=\"_ _0\"></span>wo we<span class=\"_ _0\"></span>eks<span class=\"_ _0\"></span> <br></span><span class=\"ws7b\">thereaf<span class=\"_ _0\"></span>ter</span></span>",
	"Brintellix_748a6149a0": "<span class=\"ff2 fc0 fs13\">References</span>",
	"Brintellix_747bd52629": "<div class=\"ff3 fc1\" style=\"font-size:15px;\"><span class=\"ff2\">1.</span> Katona C et al. Int Clin Pyschopharmacol 2012;27:215-223.</div>"
}
